Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio)

Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio) is a research organisation in Barcelona, Spain that has taken part in 79 EU-funded projects since 2008, receiving €31.3M in EU funding and leading 21 as coordinator.

EU funding received€31.3M
EU projects79
As coordinator21
Running now38
First EU project2008
Latest project2026
CountrySpain
EU registration (PIC)995163935
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio)'s own share of each project, not the project's full budget.

  • Horizon Europe€15.4M · 32 projects
  • Horizon 2020€7.9M · 23 projects
  • FP7 (2007 to 2013)€6.2M · 13 projects
  • EU4Health Programme (EU4H)€1.3M · 8 projects
  • Euratom Research and Training Programme (EURATOM)€400k · 2 projects
  • Digital Europe Programme (DIGITAL)€69k · 1 project

Projects

79 EU-funded projects, newest first. Fundacio Privada Institut D'Investigacio Oncologica de Vall-Hebron (Vhio) led 21 of them as coordinator. Each links to the official record.

  • SCAILEDPartner

    Scale-up biotech AI innovation by leveraging responsible data use under the European Health Data Space

    EU4Health Programme (EU4H) · 2026–2029 · Project on the EU portal ↗

    €92ktheir share
  • IRB-DRIVEAssociated partner

    IRB Barcelona International PhD Programme: Driving talent towards professional excellence and high impact biomedicine.

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

  • GRAPEPartner

    Gold Radiosensitizers for Advanced Proton therapy

    Horizon Europe · 2026–2027 · Project on CORDIS ↗

    €30ktheir share
  • tL-CHANCERCoordinator

    Unveiling the Role of T-Lymphocyte Clonal Hematopoiesis in Antitumor Immunity to Transform Cancer Immunotherapy

    Horizon Europe · 2026–2031 · Project on CORDIS ↗

    €2.0Mtheir share
  • NEOTREGPartner

    Early clinical development of first-in-class EGL-001 targeting Tregs in head and neck squamous cell carcinoma, supported by AI-based pathomics

    Horizon Europe · 2026–2028 · Project on CORDIS ↗

    €204ktheir share
  • DYNAMISAssociated partner

    IDIBAPS Doctoral programme Yielding Novel Advancements in Medicine and Innovative Solutions

    Horizon Europe · 2026–2030 · Project on CORDIS ↗

  • LIGAND-AIPartner

    Protein-ligand data generation at scale to support computational hit finding and optimization

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €238ktheir share
  • SPARCPartner

    Support of Personalized medicine Approaches in Cancer

    EU4Health Programme (EU4H) · 2025–2028 · Project on the EU portal ↗

    €75ktheir share
  • JA PCMPartner

    Joint Action Personalised Cancer Medicine

    EU4Health Programme (EU4H) · 2025–2029 · Project on the EU portal ↗

    €269ktheir share
  • SonoMYCCoordinator

    Bringing MYC inhibition to the brain by ultrasound technology

    Horizon Europe · 2025–2027 · Project on CORDIS ↗

    €150ktheir share
  • LATE-AYAPartner

    Understanding and addressing LATE-effects of treatment of AYA cancer survivors with AI-based digital phenotyping and non-invasive holistic approach

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €399ktheir share
  • EU-CIPPartner

    EUropean Cancer Information Portal

    Horizon Europe · 2025–2029 · Project on CORDIS ↗

    €102ktheir share
  • SHAIPEDPartner

    Supporting Health Data Access Bodies to establish AI pathways enabling Deployment of AI as medical device tools

    Digital Europe Programme (DIGITAL) · 2025–2028 · Project on the EU portal ↗

    €69ktheir share
  • VIDACoordinator

    VHIO International postDoctoral programme for translAtional research

    Horizon Europe · 2025–2030 · Project on CORDIS ↗

    €1.7Mtheir share
  • ENCANTPartner

    Nanoengineered particles for enhanced cancer radiotherapy

    Horizon Europe · 2025–2026 · Project on CORDIS ↗

    €20ktheir share
  • JANE-2Associated partner

    Joint Action on Networks of Expertise on Cancer

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €187ktheir share
  • TETRISPartner

    Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €400ktheir share
  • TETRISPartner

    Risk assessment Tools for severe side Effects after breasT Radiotherapy: radiation safety through biological extended models and dIgital twinS

    Euratom Research and Training Programme (EURATOM) · 2024–2027 · Project on the EU portal ↗

    €400ktheir share
  • CAT-ClinARTPartner

    Catalan Clinical Audit network for Quality Improvement in RT

    EU4Health Programme (EU4H) · 2024–2027 · Project on the EU portal ↗

    €27ktheir share
  • EUnetCCC JAAssociated partner

    The European Comprehensive Cancer Centre Network

    EU4Health Programme (EU4H) · 2024–2028 · Project on the EU portal ↗

    €531ktheir share
  • IRB-TARGETAssociated partner

    IRB Barcelona International PhD programme: on TARGET for high-impact biomedicine

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

  • SYNTHIAPartner

    Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €233ktheir share
  • MYCiMAXCoordinator

    Maximizing the use of a first clinically viable MYC inhibitor

    Horizon Europe · 2024–2029 · Project on CORDIS ↗

    €2.5Mtheir share
  • AI4LUNGSPartner

    AI-BASED PERSONALISED CARE FOR RESPIRATORY DISEASE USING MULTI-MODAL DATA IN PATIENT STRATIFICATION

    Horizon Europe · 2024–2027 · Project on CORDIS ↗

    €223ktheir share
  • JOIN4ATMPPartner

    MAP, JOIN AND DRIVE EUROPEAN ACTIVITIES FOR ADVANCED THERAPY MEDICINAL PRODUCT DEVELOPMENT AND IMPLEMENTATION FOR PATIENT AND SOCIETY BENEFIT

    Horizon Europe · 2024–2026 · Project on CORDIS ↗

    €300ktheir share
  • INTERACT-EUROPE 100Partner

    INTERACT-EUROPE 100

    EU4Health Programme (EU4H) · 2023–2026 · Project on the EU portal ↗

    €30ktheir share
  • MucOncoBotsPartner

    Drug-loaded nanobots for transmucosal delivery to mucinous tumours

    Horizon Europe · 2023–2025 · Project on CORDIS ↗

    €23ktheir share
  • PRIME-ROSEAssociated partner

    PRecisIon Cancer MEdicine RepurpOsing SystEm Using Pragmatic Clinical Trials

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

  • SagittariusPartner

    A PRECISION MEDICINE TRIAL LEVERAGING BLOOD-BASED TUMOR GENOMICS TO OPTIMIZE TREATMENT IN OPERABLE STAGE III AND HIGH-RISK STAGE II COLON CANCER PATIENTS - THE SAGITTARIUS TRIAL

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €590ktheir share
  • CCI4EUPartner

    COMPREHENSIVE CANCER INFRASTRUCTURES 4 EUROPE

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

    €408ktheir share
  • CARE1Partner

    First line randomized study platform to optimize treatment in patients with metastatic renal cell carcinoma

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €338ktheir share
  • PragmaTILCoordinator

    Pragmatic approach to Adoptive Cell Therapy (ACT) using Tumor Infiltrating Lymphocytes (TIL) in selected solid tumors

    Horizon Europe · 2023–2028 · Project on CORDIS ↗

    €1.1Mtheir share
  • MACHETECoordinator

    Unraveling the Functional Complexity of Cancer Genomes through Chromosome Engineering

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €1.6Mtheir share
  • ODELIAPartner

    Open Consortium for Decentralized Medical Artificial Intelligence

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €549ktheir share
  • PREVENTABLEAssociated partner

    CANCER PREVENTION VS CANCER TREATMENT: THE RARE TUMOUR RISK SYNDROMES BATTLE

    Horizon Europe · 2023–2026 · Project on CORDIS ↗

  • PCM4EUPartner

    Personalised Cancer Medicine for all EU citizens

    EU4Health Programme (EU4H) · 2023–2025 · Project on the EU portal ↗

    €129ktheir share
  • CGI-ClinicsPartner

    Data-driven cancer genome interpretation for personalised cancer treatment

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €498ktheir share
  • EOSC4CancerPartner

    A European-wide foundation to accelerate Data-driven Cancer Research

    Horizon Europe · 2022–2025 · Project on CORDIS ↗

    €109ktheir share
  • canSERVPartner

    Providing cutting edge cancer research services across Europe

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €680ktheir share
  • 4.UNCAN.euPartner

    A Coordination and Support Action to prepare UNCAN.eu platform

    Horizon Europe · 2022–2023 · Project on CORDIS ↗

    €105ktheir share
Show 39 more projects
  • I3LUNGPartner

    Integrative science, Intelligent data platform for Individualized LUNG cancer care with Immunotherapy

    Horizon Europe · 2022–2027 · Project on CORDIS ↗

    €891ktheir share
  • PIANOFORTEAssociated partner

    Partnership for european research in radiation protection and detection of ionising radiation : towards a safer use and improved protection of the environment and human health.

    Horizon Europe · 2022–2029 · Project on CORDIS ↗

  • PIANOFORTEAssociated partner

    Partnership for european research in radiation protection and detection of ionising radiation : towards a safer use and improved protection of the environment and human health.

    Euratom Research and Training Programme (EURATOM) · 2022–2029 · Project on the EU portal ↗

  • MultiLQB-PCCoordinator

    Multi-analyte liquid biopsy to monitor tumor genomic evolution and therapy response in advanced Prostate Cancer

    Horizon 2020 · 2022–2024 · Project on CORDIS ↗

    €173ktheir share
  • PERSIST-SEQPartner

    Building a reproducible single-cell experimental workflow to capture tumour cell persistence

    Horizon 2020 · 2021–2027 · Project on CORDIS ↗

    €375ktheir share
  • CCE_DARTCoordinator

    Building Data Rich Clinical Trials

    Horizon 2020 · 2021–2025 · Project on CORDIS ↗

    €1.2Mtheir share
  • H2OAssociated partner

    H2O Health Outcomes Observatory

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

  • EURAMED rocc-n-rollPartner

    EURopeAn MEDical application and Radiation prOteCtion Concept: strategic research agenda aNd ROadmap interLinking to heaLth and digitisation aspects

    Horizon 2020 · 2020–2023 · Project on CORDIS ↗

    €35ktheir share
  • oncNGSPartner

    NGS diagnostics in 21st century oncology: the best, for all, at all times

    Horizon 2020 · 2020–2026 · Project on CORDIS ↗

    €48ktheir share
  • Immune-ImagePartner

    Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies

    Horizon 2020 · 2019–2027 · Project on CORDIS ↗

    €433ktheir share
  • AR-DDRCoordinator

    Co-targeting androgen receptor signalling and DNA damage repair for precision therapy in advanced prostate cancer

    Horizon 2020 · 2019–2021 · Project on CORDIS ↗

    €173ktheir share
  • LEGACyPartner

    CeLac and European consortium for a personalized medicine approach to Gastric Cancer

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €550ktheir share
  • EUCANCanPartner

    EUCANCan: a federated network of aligned and interoperable infrastructures for the homogeneous analysis, management and sharing of genomic oncology data for Personalized Medicine.

    Horizon 2020 · 2019–2023 · Project on CORDIS ↗

    €344ktheir share
  • SYST-iMYCCoordinator

    Development of an effective and safe systemic Myc inhibitor for the treatment of multiple cancer types.

    Horizon 2020 · 2018–2019 · Project on CORDIS ↗

    €149ktheir share
  • EDIReXPartner

    EurOPDX Distributed Infrastructure for Research on patient-derived cancer Xenografts

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €518ktheir share
  • MESI-STRATPartner

    Systems Medicine of Metabolic-Signaling Networks: A New Concept for Breast Cancer Patient Stratification

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €220ktheir share
  • COLOSSUSPartner

    Advancing a Precision Medicine Paradigm in metastatic Colorectal Cancer: Systems based patient stratification solutions

    Horizon 2020 · 2018–2023 · Project on CORDIS ↗

    €987ktheir share
  • TRACEPartner

    Transfer of multivirus-specific T-cells following transplantation

    Horizon 2020 · 2018–2024 · Project on CORDIS ↗

    €255ktheir share
  • Wnt and CRCCoordinator

    Therapeutic inhibition of the oncogenic Wnt/beta-catenin pathway in mismatch repair deficient hypermutant tumors

    Horizon 2020 · 2017–2019 · Project on CORDIS ↗

    €170ktheir share
  • HARMONYPartner

    Healthcare Alliance for Resourceful Medicines Offensive against Neoplasms in HematologY - Sofia ref.: 116026

    Horizon 2020 · 2017–2023 · Project on CORDIS ↗

    €156ktheir share
  • GBM-CPPCoordinator

    Developing an anti-Myc cell-penetrating peptide for cancer treatment

    Horizon 2020 · 2016–2017 · Project on CORDIS ↗

    €148ktheir share
  • NoCanTherPartner

    Nanomedicine upscaling for early clinical phases of multimodal cancer therapy

    Horizon 2020 · 2016–2021 · Project on CORDIS ↗

    €348ktheir share
  • PhdPartner

    Deciphering PI3K biology in health and disease

    Horizon 2020 · 2015–2019 · Project on CORDIS ↗

    €248ktheir share
  • MoTriColorCoordinator

    Molecularly guided trials with specific treatment strategies in patients with advanced newly molecular defined subtypes of colorectal cancer (MoTriColor)

    Horizon 2020 · 2015–2020 · Project on CORDIS ↗

    €1.0Mtheir share
  • CSC-ISCoordinator

    Development of a more effective and safer therapeutic antibody for cancer treatment with a dual mechanism of action to eliminate CSCs and reactivate the tumour’s immune system.

    Horizon 2020 · 2015–2016 · Project on CORDIS ↗

    €150ktheir share
  • MedBioinformaticsPartner

    Creating medically-driven integrative bioinformatics applications focused on oncology, CNS disorders and their comorbidities (MedBioinformatics)

    Horizon 2020 · 2015–2018 · Project on CORDIS ↗

    €186ktheir share
  • MYCINHIBINCLINICCoordinator

    Pushing Myc inhibition towards the clinic

    FP7 (2007 to 2013) · 2014–2019 · Project on CORDIS ↗

    €1.7Mtheir share
  • MERCURICPartner

    A Phase Ia/b study of MEK1/2 inhibitor PD-0325901 or MEK-162 with cMET inhibitor PF-02341066 in RASMT and RASWT (with aberrant c-MET) Colorectal Cancer Patients.

    FP7 (2007 to 2013) · 2013–2019 · Project on CORDIS ↗

    €230ktheir share
  • WINTHERPartner

    WINTHERapeutics: development of a systems biology method to predict efficacy of cancer drugs to optimize individualized therapeutic decision and improve clinical outcome for cancer patients

    FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗

    €148ktheir share
  • Anti-CSCCoordinator

    Targeting Cancer Stem Cells (CSC) for the development of more effective treatments to cure cancer patients

    FP7 (2007 to 2013) · 2012–2013 · Project on CORDIS ↗

    €150ktheir share
  • Notch pathway in GSCCoordinator

    Role of Notch signaling pathway in Glioma Stem Cells

    FP7 (2007 to 2013) · 2012–2014 · Project on CORDIS ↗

    €234ktheir share
  • ONCOTRACKPartner

    OncoTrack - Methods for systematic next generation oncology biomarker development

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

  • OVER-HER2Coordinator

    OVErcoming Resistance to anti-HER2 therapy

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €1.7Mtheir share
  • RATHERPartner

    Rational Therapy for Breast Cancer: Individualized Treatment for Difficult-to-Treat Breast Cancer Subtypes

    FP7 (2007 to 2013) · 2011–2018 · Project on CORDIS ↗

    €296ktheir share
  • COLTHERESPartner

    Modelling and predicting sensitivity to targeted therapies in colorectal cancers

    FP7 (2007 to 2013) · 2011–2014 · Project on CORDIS ↗

    €334ktheir share
  • EUROCANPLATFORMPartner

    A European Platform for Translational Cancer Research

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €260ktheir share
  • PATHSEC-BCA-BMCoordinator

    Pathway-based Secretomes in Breast Cancer Biomarker Discovery

    FP7 (2007 to 2013) · 2010–2014 · Project on CORDIS ↗

    €100ktheir share
  • GLIOMACoordinator

    Molecular Mechanisms of Glioma Genesis and Progression

    FP7 (2007 to 2013) · 2008–2014 · Project on CORDIS ↗

    €1.1Mtheir share
  • NOTCH PATHWAY IN GSCCoordinator

    Role of Notch signaling pathway in Glioma Stem Cells

    FP7 (2007 to 2013) · Project on CORDIS ↗

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • DNA
  • RNA
  • amorphous semiconductors
  • artificial intelligence
  • bacteriology
  • big data
  • biomolecules
  • breast cancer
  • cardiovascular diseases
  • cells technologies
  • chromosomes
  • colorectal cancer
  • computational science
  • coronaviruses

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime